| Literature DB >> 33532739 |
Xianzhong Lau1, Pearly Jean Ai Yong2, Charles Kang Liang Lou3, Prabhakaran Munusamy1, Mahesh Sangrithi1,4.
Abstract
Here, we describe a detailed protocol for the isolation of purified populations of viable spermatogenic cells derived from the non-human primate model organism Macaca fascicularis (cynomolgus). Using fluorescence-activated cell sorting (FACS), we describe methods to isolate spermatogonia and primary spermatocytes ranging across the sub-stages of meiosis prophase I. These cell populations can be used with a variety of downstream assays, including single-cell approaches such as RNA sequencing, chromatin immunoprecipitation, quantitative RT-PCR, and immunocytochemistry. For complete details on the use and execution of this protocol, please refer to Lau et al. (2020).Entities:
Keywords: Cell biology; Cell isolation; Flow cytometry/mass cytometry; Model organisms; Single cell
Mesh:
Year: 2021 PMID: 33532739 PMCID: PMC7829259 DOI: 10.1016/j.xpro.2021.100294
Source DB: PubMed Journal: STAR Protoc ISSN: 2666-1667
Figure 1Cynomolgus macaque testis dissection
(A) Image of an adult cynomolgus macaque testis.
(B) Detachment of the epididymis from the testis.
(C) Small incision of the tunica albuginea.
(D) Dissection of tunica albuginea and separation of the seminiferous tubules from the tunica albuginea.
(E) Segmentation of testis tubule tissue into 1–2 g pieces.
Figure 2Flow cytometry analysis and gating of primary spermatocytes
(A) Gating strategy for isolating primary spermatocytes.
(B) Scatter gate drawn from unstained control to include cells of interest while excluding debris. Baseline voltages for the sample and level of autofluorescence in sample can be determined without the addition of fluorochromes.
(C) Singlet gate drawn to omit doublets which may contribute to false positives.
(D) Gate on PI negative live cells drawn from PI only control to determine cell viability.
(E) DNA gate to determine spread of cells based on nucleic acid content from Hoechst only control, and exclude cells less than 1C.
(F) Gates drawn for the collection of enriched primary spermatocytes based on their stages of meiotic prophase I.
Figure 3Flow cytometry analysis and gating of spermatogonia
(A) Gating strategy for isolating spermatogonia.
(B) Scatter gate drawn from unstained control to include cells of interest while excluding debris. Baseline voltages for the sample and level of autofluorescence in sample can be determined without the addition of fluorochromes.
(C) Singlet gate drawn to omit doublets which may contribute to false positives.
(D) Gate on PI negative live cells drawn from PI only control to determine cell viability.
(E) Gates drawn for the collection of SSEA-4 negative and positive cells.
The expected percentage of live cells and numbers of collected events from the various gated samples
| Events (rounded to nearest 10,000) | % total | |
|---|---|---|
| Total unsorted cells | 10,000,000 | |
| Live cells | 6,260,000 | 62.6 |
| A | 120,000 | 1.2 |
| B | 250,000 | 2.5 |
| C | 330,000 | 3.3 |
| D | 140,000 | 1.4 |
The expected percentage of live cells and number of collected events from the SSEA4-/+ gates
| Events | % Total | |
|---|---|---|
| Total unsorted cells | 10,000,000 | |
| Live cells | 5,500,000 | 55.0 |
| SSEA4- | 5,330,000 | 53.3 |
| SSEA4+ | 140,000 | 1.4 |
Figure 4Quality control of sorted spermatocytes using immunofluorescence
(A) Immunofluorescence for γ-H2AFX (green) and SYCP3 (red). A, representative image of a leptotene cell from gate A; B, representative image of a zygotene cell from gate B; C, representative image of a pachytene cell from gate C; and D, representative image of a diplotene cell from gate D. DNA was visualized using DAPI (blue).
(B) Stacked percentage plot representing spermatocytes at varying stages of meiosis prophase I from each gate.
The expected percentages of cells undergoing leptonema, zygonema, pachynema, and diplonema for each gate
| % | |||||
|---|---|---|---|---|---|
| Gate | Leptonema | Zygonema | Pachynema | Diplonema | Other cells |
| A | 76.1 | 5.3 | 0 | 0 | 18.6 |
| B | 1.6 | 64.5 | 21.8 | 2.4 | 9.7 |
| C | 2.2 | 18.4 | 63.7 | 15.6 | 0 |
| D | 0 | 17.1 | 54.9 | 28.0 | 0 |
| REAGENT or RESOURCE | SOURCE | IDENTIFIER |
|---|---|---|
| Mouse monoclonal anti-SSEA-4 APC-conjugated; dilution: 10 μL/106 cells | R&D Systems | Cat# FAB1435A, RRID: |
| Mouse monoclonal anti-γH2A.X (Phospho S139); dilution: 1:100 | Abcam | Cat# ab26350, RRID: |
| Rabbit polyclonal anti-SYCP3; dilution: 1:100 | Abcam | Cat# ab15093, RRID: |
| Goat polyclonal anti-mouse IgG H&L (Alexa Fluor 488); dilution: 1:500 | Abcam | Cat# ab150113, RRID: |
| Goat polyclonal anti-rabbit IgG H&L (Alexa Fluor 594); dilution: 1:500 | Abcam | Cat# ab150080, RRID: |
| Adult testis; >4 year-old | National Large Animal Research Facility | NA |
| Collagenase type I | Gibco | Cat# 17100017 |
| Dispase II | Gibco | Cat# 17105041 |
| Calcium chloride dihydrate | Sigma-Aldrich | Cat# 21097-250G |
| Hanks’ balanced salt solution | Sigma-Aldrich | Cat# H6648-500ML |
| DMEM, high glucose, HEPES | Gibco | Cat# 12430054 |
| Dulbecco’s phosphate-buffered saline | Gibco | Cat# 14190144 |
| Phosphate-buffered saline | Gibco | Cat# 10010023 |
| Fetal bovine serum | Sigma-Aldrich | Cat# F2442-100ML |
| Trypan blue solution | Sigma-Aldrich | Cat# T8154-20ML |
| Hoechst 33342, trihydrochloride, trihydrate, 10 mg/mL | Invitrogen | Cat# H3570 |
| Propidium iodide (PI), 1.0 mg/mL | Invitrogen | Cat# P3566 |
| Sucrose | Sigma-Aldrich | Cat# S0389-500G |
| Triton X-100 | Millipore | Cat# 9410-OP |
| Tween-20 | Sigma-Aldrich | Cat# P9416-100ML |
| Sodium dodecyl sulfate | Sigma-Aldrich | Cat# L3771-100G |
| 16% paraformaldehyde aqueous solution | Electron Microscopy Sciences | Cat# 15710 |
| SlowFade Gold Antifade Mountant with DAPI | Invitrogen | Cat# S36938 |
| BD FACS Diva CS&T Research Beads | BD | Cat# 655051 |
| BD FACSAccudrop Beads | BD | Cat# 345249 |
| National Large Animal Research Facility | IACUC protocol Ref. 2019/SHS/1465 | |
| BD FACS Diva 8.0.1 Software, Firmware Version 1.3 | BD | NA |
Tissue digest buffer A
| Reagent | Final concentration (mM or μM) | Amount |
|---|---|---|
| (500×) Collagenase Type 1 stock | 200 U/mL | 50 μL |
| HBSS | n/a | 24.95 mL |
Tissue digest buffer B
| Reagent | Final concentration (mM or μM) | Amount |
|---|---|---|
| (500×) Collagenase Type 1 stock solution | 200 U/mL | 50 μL |
| (100×) Dispase II stock solution | 2.4 U/mL | 250 μL |
| 1 M CaCl2 | 1 mM | 25 μL |
| HBSS | n/a | 24.675 mL |
Unstained control
| Reagent | Final concentration (mM or μM) | Amount |
|---|---|---|
| FBS | 1% | 10 μL |
| DPBS | n/a | 990 μL |
PI only control
| Reagent | Final concentration (mM or μM) | Amount |
|---|---|---|
| 1.0 mg/mL PI | 1 μg/mL | 1 μL |
| FBS | 1% | 10 μL |
| DPBS | n/a | 989 μL |
Hoechst 33342 only control
| Reagent | Final concentration (mM or μM) | Amount |
|---|---|---|
| 10 mg/mL Hoechst 33342 | 5 μg/mL | 0.5 μL |
| FBS | 1% | 10 μL |
| DPBS | n/a | 989.5 μL |
PI + Hoechst 33342 sample
| Reagent | Final concentration (mM or μM) | Amount |
|---|---|---|
| 1.0 mg/mL PI | 1 μg/mL | 10 μL |
| 10 mg/mL Hoechst 33342 | 5 μg/mL | 5 μL |
| FBS | 1% | 100 μL |
| DPBS | n/a | 9.885 mL |
SSEA-4 APC-conjugated Ab stain solution
| Reagent | Final concentration (mM or μM) | Amount |
|---|---|---|
| Mouse monoclonal anti-SSEA-4 APC-conjugated Antibody | 10 μL/106 cells | Dependent on cell concentration |
| FBS | 1% | 10 μL |
| DPBS | n/a | 990 μL |
Collection media
| Reagent | Final concentration (mM or μM) | Amount |
|---|---|---|
| FBS | 10% | 2 mL |
| DMEM | n/a | 18 mL |
Freezing media
| Reagent | Final concentration (mM or μM) | Amount |
|---|---|---|
| FBS | 20% | 4 mL |
| DMSO | 10% | 2 mL |
| DMEM | n/a | 14 mL |
PFA fixative solution
| Reagent | Final concentration (mM or μM) | Amount |
|---|---|---|
| 16% PFA | 2% | 250 μL |
| 10% SDS | 0.02% | 4 μL |
| PBS | n/a | 1.746 mL |
Blocking buffer
| Reagent | Final concentration (mM or μM) | Amount |
|---|---|---|
| 10% BSA | 0.15% | 30 μL |
| 10% Tween-20 | 0.2% | 40 μL |
| PBS | n/a | 1.93 mL |
Primary antibody mix
| Reagent | Final concentration (mM or μM) | Amount |
|---|---|---|
| Mouse monoclonal anti-γH2AFX (Phospho S139) | 1:100 | 10 μL |
| Rabbit polyclonal anti-SYCP3 | 1:100 | 10 μL |
| Blocking Buffer | n/a | 980 μL |
Secondary antibody mix
| Reagent | Final concentration (mM or μM) | Amount |
|---|---|---|
| Goat polyclonal anti-mouse IgG H&L (Alexa Fluor 488) | 1:500 | 2 μL |
| Goat polyclonal anti-rabbit IgG H&L (Alexa Fluor 594) | 1:500 | 2 μL |
| Blocking Buffer | n/a | 996 μL |